Market Size –
The genital herpes market size has grown strongly in recent years. It will grow from $2.05 billion in 2023 to $2.19 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing awareness and diagnosis, increasing advancements in treatment, improved access to healthcare, public health campaigns, and socio-demographic factors.
The genital herpes market size is expected to see strong growth in the next few years. It will grow to $2.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to growing awareness and education, advancements in treatment and vaccines, increasing incidence rates, digital health technologies, expanding healthcare access, and rising STI awareness programs. Major trends in the forecast period include adoption of telemedicine, advancements in antiviral therapies, research and development in vaccines, expansion of healthcare access, enhanced public awareness campaigns, and the and the integration of AI and data analytics.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report
Scope Of Genital Herpes Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Genital Herpes Market Overview
Market Drivers –
The rising focus on sexual health is expected to propel the growth of the genital herpes market going forward. The rising focus on sexual health stems from increasing recognition of its significant role in overall health and quality of life. The use of sexual health services for genital herpes primarily involves diagnosis, treatment, counseling, and ongoing management to support individuals in managing outbreaks, preventing transmission, and addressing emotional and relationship concerns associated with the condition. For instance, in January 2024, according to the Local Government Association, a UK-based national membership body, the demand for sexual health services increased, with nearly 4.5 million consultations conducted in 2022, marking a 33% increase. Moreover, diagnostic testing also saw significant activity, with 2.2 million tests performed in 2022, representing a 13% rise compared to 2021. Therefore, the rising focus on sexual health will drive the growth of the genital herpes market.
Market Trends –
Major companies operating in the genital herpes market are adopting a strategic partnership approach to enhance technological capabilities and market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in June 2022, Eurocine Vaccines AB, a Sweden-based biotechnology company specializing in herpes disease treatment therapies and products, announced a research and collaboration agreement with Redbiotec AG, a Switzerland-based biotech company, granting exclusive global rights for the development, manufacturing, and commercialization of vaccine candidates targeting Herpes Simplex Virus Type 2 (HSV-2). The agreement encompasses both mRNA- and protein-based technologies, including associated documentation and patents in the HSV-2 field. Eurocine Vaccines will oversee and fund all activities related to development, manufacturing, and commercialization until a subsequent out-licensing agreement with a third party is finalized.
The genital herpes market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Route Of Administration: Oral, Injectable, Topical
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel
Get an inside scoop of the genital herpes market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=17161&type=smp
Regional Insights –
North America was the largest region in the genital herpes market in 2023. The regions covered in the genital herpes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the genital herpes market are Pfizer Inc, Roche Holding AG, Merck & Co. Inc. , AbbVie Inc., Sanofi SA, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, BioNTech SE , Viatris Inc, Teva Pharmaceuticals Inc, Sandoz Inc, Fresenius Kabi AG, Valeant Pharmaceuticals International Inc, Sun Pharmaceutical Industries Ltd, Bausch + Lomb Corporation, Dr Reddy’s Laboratories Ltd, Apotex Inc, Zydus Group, Genocea Biosciences Inc, Glenmark Pharmaceuticals Inc, Maruho Co Ltd, Romark Laboratories, Eurocine Vaccines AB , Vical Incorporated
Table of Contents
1. Executive Summary
2. Genital Herpes Market Report Structure
3. Genital Herpes Market Trends And Strategies
4. Genital Herpes Market – Macro Economic Scenario
5. Genital Herpes Market Size And Growth
…..
27. Genital Herpes Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
